That is an awkward number
Implications for Compounding Pharmacies and Prescribers (and Outsourcing Facilities) The April 1 clarification, read alongside FDA's escalating enforcement posture since early 2026, may signal a maturing and increasingly restrictive regulatory environment for GLP-1 compounding
However, asundexian could still become a viable option if its second stroke prevention trial succeeds
Not every patient needs this, but for patients with significant muscle mass concerns older adults, perimenopausal women, patients losing weight quickly at high doses it is worth considering
Since SciSafe first became registered for CBER in 2011 and CDER in 2018, the FDA has inspected our locations seven times - and we have received no 483 findings, which are observations regarding conditions or practices that indicate an FDA-regulated product may be in violation of requirements
HIIT (High-Intensity Interval Training): Alternate 30 seconds of all-out effort (like sprinting or burpees) with 30 seconds of rest for incredible fat-burning results